Baird Financial Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $706K | Buy |
|
|||||
|
2023
Q2 | $1.53M | Sell |
|
|||||
|
2023
Q1 | $1.98M | Buy |
|
|||||
|
2022
Q4 | $1.1M | Buy |
|
|||||
|
2022
Q3 | $1.59M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.35M | Buy |
|
|||||
|
2021
Q2 | $1.16M | Buy |
|
|||||
|
2021
Q1 | $762K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $484K | Buy |
|
|||||
|
2020
Q2 | $384K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1.28M | Sell |
|
|||||
|
2016
Q1 | $1.85M | Buy |
|
|||||
|
2015
Q4 | $2.82M | Buy |
|
|||||
|
2015
Q3 | $2.07M | Buy |
|
|||||
|
2015
Q2 | $1.09M | Buy |
|